GH
GH Research
GHRS·NASDAQDublin IEFounded 201830 employees
Small CapbiotechPublicCNS
Platform: 5-MeO-DMT Psychedelic
Market Cap
$1B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (GHRS)
Loading GHRS stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Niraratamab | GHR-6130 | Phase 2/3 | 1 | RET | AsthmaMDD | ||
| Elratuximab | GHR-278 | NDA/BLA | 1 | PI3Kα | MSIgAN |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)